TTG Index Charts & Out of the Box Stock Screen 9/13/23
Out of the Box MarketWebs Screen
US Dollar +0.1% / 30yr Bonds -0.4% / Crude +0.6% & Nat Gas +0.4% / Copper -0.1% / Cryptos are higher BTC +0.5%
Upcoming US Economics
note S&P options are implying a 65 bps move for today
Index Updates
At TTG, I use Volume At Price in my chart analysis and I use the MarketWebs Indicator to provide Value Areas which indicate significant support & resistance levels. Learn More Here about Volume At Price and the MarketWebs.
$ES_F - S&P futures - Daily chart: Once again not much change in the technical picture here.. other than price drifting a little lower and below its short term MAs (Moving Averages).. Price remains inside its Sept Value Area. Bottom of Value support is 4467.75 / top of Value resistance 4591.25. Note CPI report at 8:30est.
1hr chart: Price remains inside its Value Area for the week = sideways
QQQ - NDX 100 ETF - Daily chart: New development here, price rallied above its Sept Value Area & back above its short term MAs (Moving Averages) support is now $375.29
1hr chart: Price fell yesterday after that VPOC take out (red line) and now is back inside the Value Area for the week = sideways
IWM- Russell Small Cap ETF- Daily Chart: Price continues to hover around its 200d MA and bottom of Sept Value Area. For a short opportunity, watch for a break of $181.96
1hr chart: Price remains inside its Value Area for week, support to watch $183.51
Here is today’s TTG Proprietary Stock Screen “Out of the Box” using Volume At Price
Remember, I am only showing a few setups from the list here and review more in the TTG Trading Room. I provide a more detailed watchlist every weekend to start the week at TTG.
Charts
ALKS Weekly & Daily chart
Alkermes PLC researches pharmaceuticals. The Company develops treatments for central nervous system disorders such as addiction, schizophrenia and depression, and diabetes.
Alkermes is working some medicinal alchemy. The firm uses its proprietary drug-delivery systems to make compounds that require less frequent dosing or provide more targeted delivery. Focusing primarily on psychiatric medications, it has a couple of drugs on the market that use its injectable extended-release technology, which lets patients take a drug once or twice a month, rather than once or twice a day. One such drug is Risperdal Consta, a long-acting version of Johnson & Johnson's schizophrenia and bipolar I medication Risperdal. Another is Vivitrol, a treatment for alcohol dependence. Alkermes plc was formed in September 2011 through the merger of US-based Alkermes Inc. and Elan Drug Technologies (EDT). (Bloomberg)
-suggested stop price $27.5 using the TTG MarketWebs
Copyright © Tribeca Trade Group. All of the information in this newsletter is for entertainment and educational purposes only and is not to be construed as investment or trading advice. None of the information in this newsletter is guaranteed to be accurate, complete, useful or timely. IMPORTANT NOTICES AND DISCLAIMERS TriBeCa Trade Group is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of TriBeCa Trade Group are not acting as investment advisors and might not be registered with the U.S. Securities Authority